In 21 patients, 90 simultaneous renal clearances of inulin and sodium iothalamate 1251, and para-amino-hippuric acid (PAH) 
SUMMARY
In 21 patients, 90 simultaneous renal clearances of inulin and sodium iothalamate 1251, and para-amino-hippuric acid (PAH) and iodopyracet 1311 were determined by a constant infusion technique. The activities of iothalamate 1251 and iodopyracet 131I were determined simultaneously in a dual-channel scintillation counter. The concentrations of inulin and PAH were determined by standard chemical techniques. that of inulin, sulfonamides give the same color reaction. The simplicity and accuracy with which the activity of gamma-emitting isotopes can be quantitated have facilitated the measurement of renal hemodynamics by the use of radio-labeled compounds whose clearances are the same as either inulin or PAH. The availability of sodium iodide crystal scintillation counters equipped with dual-channel pulse-height analyzers has made possible the development of double-isotope techniques. This paper reports the use of iothalamate 125J* and iodopyracet 1311* for the measurement of GFR and ERPF in man.
Methods Twenty-one patients with various diseases were selected so that all levels of renal function would be represented. In 17 patients bladder clearances and in four patients individual kidney clearances were done. Bladder clearances were performed twice on one patient. Twenty-six studies were done in all. Diuresis was initiated with an UV, where C is the clearance in ml/min, V the urine flow in ml/min, U the urine, and P the plasma concentration. The activities of iothalamate 125I and iodopyracet 1311 were expressed in net counts/min/ml and those of inulin and PAH in mg/ml. The free iodine content of iothalamate 1251 and iodopyracet 131I was determined by paper chromatography on several but not all lots of radioisotopes and was found to be less than 1.5%.*
Results
The results of 90 clearances from 26 studies on 21 patients are shown in bound by plasma proteins, neither reabsorbed nor excreted by the renal tubules, and easily quantitated. Inulin has been the substance thought to best meet these criteria, and recent micropuncture studies in the rat have indeed shown complete recovery from a distal site of inulin injected proximally. 6 Yet, the chemical determination of inulin remains troublesome. This difficulty has been overcome by the use of radioactive compounds excreted by glomerular filtration. Allyl inulin 125I is a satisfactory substitute, but the radioiodine tends to become detached from the parent molecule, and free iodine must be removed before use.7 57Cobalt-labeled vitamin B12 provides an accurate measure of GFR but requires the prior injection of stable B12 to saturate protein-binding sites and the use of a factor to correct for this binding. 8 The renal excretion of the newer tri-iodinated benzoic acid derivatives used as contrast media appears to be solely by glomerular filtration. The clearances of radioiodinated forms of the sodium (Hypaque9) and meglumine (Renografin'0) salts of diatrizoate and the sodium salt of its isomer, iothalamate (Conray11) have approximated those of inulin in man. Evidence that iothalamate 131I is not excreted by the renal route in aglomerular fish and that changes in its concentration in tubular fluid during stop-flow studies on the dog parallel those of inulin strongly suggests that no difference exists between the renal handling of inulin and iothalamate.12
Iodopyracet was the first substance widely used for the measurement of ERPF, but it was determined by a complicated chemical method which involved measurement of the amount of iodopyracet iodine present. 13 The finding that PAH and iodopyracet at low plasma concentrations had identical clearances and extraction ratios and that the chemical determination of PAH was much simpler led to the substitution of PAH for iodopyracet.14 The introduction of gamma-emitting isotopes into clinical medicine has allowed further simplification of the measurement of ERPF. Although PAH had no place in its molecular structure for the substitution of a gamma-emitting atom, ortho-iodo-hippurate (OIH), previously shown to have renal clearances identical with those of PAH,4 was easily labeled with radioiodine by the process of free substitution. Contrary to expectations, the OIH 1311/PAH clearance ratio ranged from only 0.84 to 0.88, a finding that could be accounted for only in part by the presence of free iodine in commercially available preparations. This disappointment with OIH led us to reconsider the use of iodopyracet 131I for the measurement of ERPF, even though earlier studies had shown that clearances of tracer doses of iodopyracet l31I were consistently 20% to 25% lower than those of PAH.18 A possible explanation for this discrepancy became apparent when radioactive tracer dos- 
